Filing Details
- Accession Number:
- 0001638599-19-000654
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-07-15 17:46:39
- Reporting Period:
- 2019-07-11
- Accepted Time:
- 2019-07-15 17:46:39
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1682639 | Eyenovia Inc. | EYEN | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1396235 | H Curt Labelle | C/O Eyenovia, Inc. 295 Madison Avenue, Suite 2400 New York NY 10017 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $.0001 | Acquisiton | 2019-07-11 | 17,985 | $2.78 | 27,985 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock, Par Value $.0001 | 606,667 | Indirect | By Private Medical Equity, Inc. |
Common Stock, Par Value $.0001 | 453,333 | Indirect | By PME Investor Services Eyenovia, LLC |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | $1.24 | 2015-03-02 | 2025-03-02 | 40,000 | 40,000 | Direct |
Common Stock | Stock Option (right to buy) | $1.95 | 2027-07-07 | 133,334 | 133,334 | Direct | |
Common Stock | Stock Option (right to buy) | $1.24 | 2015-03-23 | 2025-03-23 | 140,000 | 140,000 | Indirect |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2025-03-02 | 40,000 | 40,000 | Direct |
2027-07-07 | 133,334 | 133,334 | Direct |
2025-03-23 | 140,000 | 140,000 | Indirect |
Footnotes
- The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- The option became exercisable as to 3,704 shares on August 7, 2017, and becomes exercisable in equal 3,704 share amounts on each of the 35 one-month anniversaries thereafter.